News articles about CME Group (NASDAQ:CME) have been trending somewhat positive on Monday, Accern Sentiment reports. The research group scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. CME Group earned a news impact score of 0.09 on Accern’s scale. Accern also assigned media headlines about the financial services provider an impact score of 46.6925263451302 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Here are some of the media headlines that may have impacted Accern Sentiment’s analysis:
- $1.50 EPS Expected for CME Group Inc (CME) This Quarter (americanbankingnews.com)
- CME September 28th Options Begin Trading (nasdaq.com)
- Insider Selling: CME Group Inc (CME) Director Sells 260 Shares of Stock (americanbankingnews.com)
- CME Group Inc (CME) Given Consensus Recommendation of “Buy” by Brokerages (americanbankingnews.com)
- Hot Stock Spotlight: CME Group Inc. (CME) (nysedaily.com)
Several research analysts recently weighed in on CME shares. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a report on Monday, July 16th. Zacks Investment Research cut shares of CME Group from a “buy” rating to a “hold” rating in a report on Tuesday, June 5th. Wells Fargo & Co boosted their price target on shares of CME Group from $170.00 to $175.00 and gave the stock a “market perform” rating in a report on Monday, July 9th. Finally, Compass Point started coverage on shares of CME Group in a report on Monday, July 9th. They set a “neutral” rating and a $170.00 price target on the stock. Six investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $170.29.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, July 26th. The financial services provider reported $1.74 EPS for the quarter, topping the consensus estimate of $1.72 by $0.02. The business had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. CME Group had a net margin of 111.45% and a return on equity of 9.03%. The company’s revenue for the quarter was up 14.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.22 earnings per share. research analysts predict that CME Group will post 6.68 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 25th. Shareholders of record on Monday, September 10th will be given a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 1.71%. The ex-dividend date of this dividend is Friday, September 7th. CME Group’s dividend payout ratio is 58.70%.
In other news, Director Martin J. Gepsman sold 600 shares of the business’s stock in a transaction that occurred on Friday, May 25th. The shares were sold at an average price of $159.77, for a total value of $95,862.00. Following the sale, the director now owns 42,411 shares of the company’s stock, valued at $6,776,005.47. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Ronald A. Pankau sold 250 shares of the business’s stock in a transaction that occurred on Thursday, June 7th. The shares were sold at an average price of $171.51, for a total transaction of $42,877.50. Following the completion of the sale, the director now directly owns 3,559 shares in the company, valued at approximately $610,404.09. The disclosure for this sale can be found here. In the last ninety days, insiders sold 44,654 shares of company stock worth $7,234,893. Insiders own 0.57% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Further Reading: Understanding Analyst Ratings
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.